Home NDC 52605-043-19 amlodipine besylate
Product NDC 52605-043
Requested package NDC 52605-043-19
11-digit product format 526050043
Labeler code 52605
Product ID 52605-043_83e3e459-c254-45e3-a5ac-2e717e08c348
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name amlodipine besylate
Dosage form TABLET
Route ORAL
Labeler POLYGEN PHARMACEUTICALS INC.
Application ANDA207821
Marketing category ANDA
Marketing start 2016-07-11
Substance AMLODIPINE BESYLATE
Active strength 10 mg/1
Pharmacologic classes Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 1 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 52605-043 52605-043-19 I Inactivated by FDA excluded / ndc_excluded.zip 9bebd1f3094a…5416666fcb17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A207821-001 AMLODIPINE BESYLATE AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 A207821-002 AMLODIPINE BESYLATE AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 A207821-003 AMLODIPINE BESYLATE AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207821-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 A207821-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11 84e616aacf4f…2026-08-18 06:07:40 2026-07 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207821-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A207821-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207821-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A207821-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207821-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A207821-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A207821-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A207821-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207821-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A207821-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207821-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A207821-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207821-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A207821-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207821-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A207821-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207821-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A207821-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A207821-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A207821-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A207821-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A207821-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A207821-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2016-07-11 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A207821-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2016-07-11 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A207821-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2016-07-11 301d65b070ca…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 129 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 52605-043-10 amlodipine besylate 1000 in 1 BOTTLE TABLET 1000 8 52605-043-19 amlodipine besylate 90 in 1 BOTTLE TABLET 90 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 52605-043 AMLODIPINE BESYLATE TABLET [POLYGEN PHARMACEUTICALS INC.] 8 Current NDC, Legacy NDC, 2 package rows 20221130_f5fbfd12-a600-482d-a306-5d6c09ae4210.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 52605-043-19 52605004319 90 TABLET in 1 BOTTLE (52605-043-19) 90 tablet 2016-07-11 0000-00-00 No No Current